← Back to headlines
US Company Reports Positive Results for New Alzheimer's Drug in Mid-Stage Trials
A US pharmaceutical company announced that its new Alzheimer's treatment drug has shown effectiveness in slowing symptom progression during mid-stage clinical trials. The company plans to proceed with final-stage trials for potential practical application.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Oldest Known Plague Outbreak Discovered in Siberia Dating Back 5,500 Years
just now
Extreme Training: What Heat Training Does to the Body
just now
Philippines Faces Water Shortage as Angat Dam Dips Below Critical, El Niño Mitigation Underway
just now
Are Mumbai schools closed amid IMD’s orange alert? Institutions shut in Palghar, BMC updates on closures
23m ago